SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-21-061774
Filing Date
2021-11-24
Accepted
2021-11-24 09:29:51
Documents
9

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-1 ea151108-s1a1_raphaelpharma.htm S-1/A 1349979
2 OPINION OF SULLIVAN & WORCESTER LLP ea151108ex5-1_raphael.htm EX-5.1 9858
3 CONSENT OF BRIGHTMAN ALMAGOR ZOHAR & CO ea151108ex23-2_raphael.htm EX-23.2 3195
4 GRAPHIC image_001.jpg GRAPHIC 11420
5 GRAPHIC image_002.jpg GRAPHIC 35039
6 GRAPHIC image_003.jpg GRAPHIC 7012
7 GRAPHIC image_004.jpg GRAPHIC 4950
8 GRAPHIC ex5-1_001.jpg GRAPHIC 17646
9 GRAPHIC ex5-1_002.jpg GRAPHIC 5947
  Complete submission text file 0001213900-21-061774.txt   1477874
Mailing Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108
Business Address SUITE 105 - 5348 VEGAS DR. LAS VEGAS NV 89108 702-442-1166
Raphael Pharmaceutical Inc. (Filer) CIK: 0001415397 (see all company filings)

IRS No.: 260204284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-260766 | Film No.: 211441475
SIC: 2833 Medicinal Chemicals & Botanical Products